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Technical terms and definitions 
Definitions are based on the 2006 CDNA Guidelines for the public health management of trachoma in Australia.1 
Active trachoma: The presence of chronic inflammation of the conjunctiva caused by infection with Chlamydia 
trachomatis; includes World Health Organization grades trachomatous inflammation - follicular (TF) and 
trachomatous inflammation - intense (TI). 
At-risk communities: Communities classified by jurisdictions as being at higher risk of trachoma (generally based on 
prevalence above 5% in age group 5-9 years). 
Clean face: Absence of dirt, dust and crusting on cheeks and forehead. 
Community screening coverage: The number of communities screened for trachoma as a proportion of communities 
designated by jurisdictions to be at risk of trachoma. 
Contacts: Includes all members of the household or households in which a person with active trachoma regularly 
sleeps. However, where the community prevalence was greater than 10%, this term includes all members of the 
community, not only household members. 
Endemic trachoma: Prevalence of active trachoma of 5% or more in children aged 1-9 years or a prevalence of 
trichiasis of at least 0.1% in the adult population.  
Hyperendemic trachoma: Prevalence of active trachoma of 20% or more in children aged 1-9 years. 
Prevalence of active trachoma: Proportion of people found in a screening program to have active trachoma. 
Screening coverage: The proportion of people in a population examined for trachoma or trichiasis through a 
screening program. 
Trachomatous inflammation - follicular (TF): Presence of five or more follicles in the upper tarsal conjunctiva, each 
at least 0.5 mm in diameter, as observed through a loupe. 
Trachomatous inflammation - intense (TI): Pronounced inflammatory thickening of the tarsal conjunctiva that 
obscures more than half of the normal deep tarsal vessels. 
Trachomatous trichiasis (TT): Evidence of the recent removal of in-turned eyelashes or at least one eyelash rubbing 
on the eyeball. 
Treatment coverage: The proportion of people requiring treatment for trachoma under guidelines who actually 
received treatment. 
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Australian trachoma surveillance 2012: Executive summary 
Trachoma screening and management data for 2012 were provided to the National Trachoma Surveillance and 
Reporting Unit by the Northern Territory (NT), South Australia (SA), Western Australia (WA) and Queensland (Qld). 
Data were analysed by region in the NT, SA and WA, with five regions in the NT, four in SA and four in WA. 
Queensland screened six communities and its data was aggregated for analysis. Jurisdictional authorities had 
designated 204 remote Aboriginal communities as being at risk of endemic trachoma in 2012. 
Screening coverage 
• A total of 195 (96%) of 204 at-risk communities were screened for trachoma during 2012 (Table 1.1). 
• Within these communities, 5426(71%) of an estimated 7676 resident children aged 5-9 years were screened. 
• Screening coverage in children aged 5-9 years in at-risk communities was 67% for the NT, 79% for SA, 73% 
for WA and 64% for Qld (Table 1.1). 
• Screening coverage of 5-9-year-old children in 2012 increased in NT, SA and WA (Figure 1.3) 
Clean face prevalence 
• A total of 5473 children aged 5-9 years in 193 at-risk communities were assessed for clean faces during 2012 
(Table 1.1). 
• The overall prevalence of clean faces in children aged 5-9 years was 79%, with 75% in the NT, 90% in SA, 81% 
in WA and 70% in Qld (Table 1.1, Figure 1.4). 
• The proportion of screened communities with over 80% of children aged 5-9 years having a clean face was 
58% in the NT, 89% in SA, 57% in WA and 33% in Qld (Figure 1.5). 
Trachoma prevalence 
• The overall prevalence of active trachoma among children aged 5-9 years in screened communities was 4%, 
with 4% in the NT and WA, 2% in SA, and nil in Qld (Table 1.1). 
• The prevalence of trachoma in 5-9-year-old children decreased since the last report in NT, SA and WA (Figure 
1.6). 
• Of all communities that screened 5-9-year-old children, 63% (121/193) had no trachoma detected (Figure 
1.9). 
• In 25% (48/193) of all communities that screened 5-9-year-old children endemic levels of trachoma (over 
5%) were found (Figure 1.9). 
 • In 8% (15/193) of all communities that screened 5-9-year-old children, hyperendemic levels of trachoma 
(over 20% prevalence of trachoma) were found (Figure 1.9). 
• The proportion of screened communities with no trachoma detected increased in the NT by 20%, in SA by 
21% and in WA by 3% in 2012 compared to 2011. 
• The proportion of screened communities with endemic trachoma (> 5% prevalence) decreased in the NT, SA 
and WA in 2012 compared to 2011 (Figure 1.8). 
• Follicles consistent with Trachomatous inflammation – follicular were observed in one community in Qld, 
however PCR tests results were negative for Chlamydia trachomatis. 
14 
 
Treatment coverage 
• Trachoma cases requiring treatment were detected in 87 of 195 communities screened (Table 1.2). 
• Of all cases detected that required treatment, 95% received treatment (Table 1.2). 
• Estimated treatment coverage of contacts was 81% overall, 79% in the NT, 97% in SA and 93% in WA (Table 
1.2). 
• No treatment was required for Qld (Table 1.2). 
Trichiasis 
• Trichiasis screening coverage of adults over 40 years of age increased in the NT, WA and SA. 
• A total of 4468 (31%) adults of an estimated at-risk population of 13406 were reported to have been 
screened for trichiasis across the NT, SA and WA (Table 1.3). 
• Overall trichiasis prevalence among those screened was 2% with 61 cases reported in the NT, 11 in SA, and 
22 in WA. 
• Trichiasis surgery was reported as undertaken for 16 people with trichiasis in 2012. 
Health promotion activities  
• Of the at-risk communities screened, health promotion activities were reported to be taking place in 133 
communities across all jurisdictions 
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Background 
 
Trachoma is one of the major causes of preventable blindness globally.2 It is an eye infection caused by the bacteria 
Chlamydia trachomatis serotypes A, B, Ba and C. The infection can be transmitted through close facial contact, hand-
to-eye contact, via fomites (towels, clothing and bedding) or by flies. Trachoma generally occurs in dry, dusty 
environments and is linked to poor living conditions. Overcrowding of households, limited water supply for bathing 
and general hygiene, poor waste disposal systems and high numbers of flies have all been associated with trachoma. 
Children generally have the highest prevalence of trachoma and are believed to be the main reservoirs of infection, 
because the infection in children has a longer duration than in adults. 
 
Infection with the relevant C. trachomatis serotype causes inflammation of the conjunctiva. Diagnosis of trachoma is 
by visual inspection, and the detection of follicles (white spots) and papillae (red spots) on the inner upper eye lid. 
Repeated infections with C. trachomatis, especially during childhood, may lead to scarring with contraction and 
distortion of the eyelid, which may in turn cause the eyelashes to rub against the cornea; this condition is known as 
trichiasis and can lead to blindness.1, 3 Scarring of the cornea due to trichiasis is irreversible. However, if early signs of 
in-turned eyelashes are found, then surgery is usually effective in preventing further damage to the cornea. 
Trachoma is usually treated by a single dose of azithromycin. Best public health practice involves treatment of all 
members of the household in which a case resides, whether or not they have evidence of trachoma. Depending on 
the prevalence of trachoma in a community, treatment may also be extended to all children aged 6 months to 14 
years, or to all members of the community, excluding or including infants less than 6 months of age.4 
The Alliance for the Global Elimination of Blinding Trachoma by 2020 (GET 2020) initiative, supported by the World 
Health Organization (WHO), advocates the implementation of the SAFE strategy, with its key components of Surgery 
(to correct trichiasis), Antibiotic treatment, Facial cleanliness and Environmental improvements. This strategy is 
ideally implemented through a primary care model within a community framework, ensuring consistency and 
continuity in screening, control measures, data collection and reporting, as well as the building of community 
capacity.5, 6 
Trachoma control in Australia 
Australia is the only high income country where trachoma is endemic. It occurs primarily in remote and very remote 
Aboriginal communities in the Northern Territory (NT), South Australia (SA) and Western Australia (WA). In 2008, 
cases were also found in New South Wales (NSW) and Queensland (Qld), where trachoma was believed to have been 
eliminated.4,7,8 In 2009, the Australian Government invested in  the Closing the Gap - Improving Eye and Ear Health 
Services for Indigenous Australians measure which included committing $16 million over a 4-year period towards 
eliminating trachoma in Australia. The funding is for improving and expanding screening and control activities, as 
well as establishing a strong framework for monitoring and evaluation. As a result, an increased level of funding was 
provided to NT, SA and WA for trachoma control activities from 1 July 2010 and to Qld and NSW in 2012. 
The surveillance and management of trachoma is guided by the Communicable Disease Network of Australia (CDNA) 
2006 Guidelines for the public health management of trachoma in Australia.1 This document was developed in the 
context of the WHO SAFE strategy and makes recommendations for improving data collection, collation and 
reporting systems. 
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The National Trachoma Surveillance and Reporting Unit  
The National Trachoma Surveillance and Reporting Unit (NTSRU) is responsible for data collation, analysis and 
reporting related to the ongoing evaluation of trachoma control strategies in Australia. It operates under contract 
with the Australian Government’s Department of Health and Ageing. The primary focus from 2006 until and 
including 2011 (report produced in 2012) has been the three jurisdictions (NT, SA and WA) funded by the Australian 
Government to undertake trachoma control activities. In 2012 the Qld Department of Health was funded to 
undertake a baseline screening of remote communities to establish whether trachoma was public health concern in 
Qld. These data are included in the 2012 report along with WA, NT and SA data.  From the end of 2010, the NTSRU 
has been managed by The Kirby Institute at the University of New South Wales.9 It was previously managed by The 
Centre for Eye Research Australia (2006 to 2008) 10,11,12 and the Centre for Molecular, Environmental, Genetic and 
Analytic Epidemiology, The University of Melbourne (2009).13 
Methodology 
Each jurisdiction undertook screening and treatment for trachoma according to its respective protocols, and in the 
context of the national 2006 CDNA Guidelines for the public health management of trachoma in Australia, which 
recommend specific treatment strategies depending on the prevalence of trachoma detected through screening.1  
In 2006, when the National Trachoma Management Program was initiated, each jurisdiction identified at-risk 
communities from historical prevalence data and other knowledge. Over time, additional communities have been 
reclassified as being at -risk. Screening for trachoma focuses on the at-risk communities, but a small number of other 
communities designated as not-at-risk have also been screened, generally if there is anecdotal information 
suggesting the presence of active trachoma. 
The WHO trachoma grading criteria (Appendix 1) were used to diagnose and classify individual cases of trachoma in 
all jurisdictions except Qld. Data collection forms (Appendix 2) for data collection at the community level were 
developed by the National Trachoma Surveillance and Control Reference Group, based on the CDNA Guidelines. 
Completed forms were forwarded from the jurisdictional coordinators to the NTSRU for checking and analysis. 
Information provided to the NTSRU at the community level for each calendar year included: 
• Number of Aboriginal children aged 1-14 years screened for clean faces and the number with clean faces, by 
age group; 
• Number of Aboriginal children aged 1-14 years screened for trachoma and the number with trachoma, by 
age group; 
• Number of episodes of treatment for active trachoma, household contacts and other community members, 
by age group; 
• Number of Aboriginal adults screened for trichiasis, number with trichiasis, and the number who had surgery 
for trichiasis; 
• Community level implementation of WHO SAFE strategies. 
Northern Territory 
Trachoma screening and management in the NT was undertaken through collaboration between the Department of 
Health (Centre for Disease Control and Health Development) and Aboriginal Community Controlled Health Services 
(ACCHS). Trachoma screening was incorporated into the Healthy School-Age Kids (HSAK) program13 annual check and 
conducted by either local primary health-care services or community-controlled services, with support from the 
Centre for Disease Control (CDC) Trachoma Team. Following screening, treatment was generally undertaken by 
primary health-care services with support from the CDC Trachoma Team when requested. 
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In 2012, community screening for trichiasis was undertaken primarily by clinic staff, ACCHS, or by optometrists or 
ophthalmologists from the Regional Eye Health Service based in Alice Springs.  In two large communities in the NT, 
mass trichiasis screening of all Indigenous adults aged over 40 years was conducted with assistance from CDC 
Trachoma Team staff. 
South Australia 
In 2012, Country Health South Australia was responsible for managing the SA trachoma screening and treatment 
program. Country Health South Australia contracted with local health service providers, Aboriginal community-
controlled health services, the Aboriginal Health Council of South Australia and Nganampa Health Service to ensure 
coverage of screening services in all at-risk rural and remote areas. Additional screening activities were undertaken 
by the Eye Health and Chronic Disease Specialist Support Program (EH&CDSSP), coordinated by the Aboriginal Health 
Council of South Australia and supported by the Medical Specialist Outreach Assistance Program (MSOAP). This 
program provides regular visits to SA remote Aboriginal communities by optometrists and ophthalmologists. 
Trichiasis screening was undertaken opportunistically for adults by both the EH&CDSSP team and the trachoma 
screening service providers, and is also undertaken routinely as part of the Adult Annual Health Checks. Country 
Health South Australia has changed regional structure in years 2011 and 2012 and therefore data from these reports 
cannot be directly compared with previous reports. 
 Western Australia 
Trachoma screening and management in WA is the responsibility of Population Health Units (PHUs) in the Kimberley, 
Goldfields, Pilbara and Midwest health regions. In collaboration with the local primary health-care providers, the 
PHUs screened communities in each region within a 2-week period, usually at the end of August or early September. 
People identified with active trachoma were treated at the time of screening. 
Trichiasis screening was undertaken in conjunction with adult influenza vaccinations. Screening of the target 
population also occurs with the Visiting Optometrist Scheme (VOS) program in the Kimberley region. 
In 2011, the government of WA changed the definition of community, specifically amalgamating several previously 
distinct communities into one single community. This definition alters trends presented in reports from 2010-2012. 
Queensland 
In 2012 Qld undertook a one-off screening exercise in six remote communities in three regions that were considered 
to be potentially at risk. This screening was undertaken by the Queensland Health’s Deadly Ears Program and 
supported by an ophthalmologist. Queensland screened according to CDNA Guidelines for areas of low prevalence or 
endemicity, which recommend using the WHO grading system to identify possible trachoma cases.  
No trichiasis screening was required to be undertaken. 
Data analysis 
For the purpose of this report, a community is defined as ‘a specific location where people reside and where there is 
at least one school.’ Community coverage is defined as the number of at-risk communities screened for trachoma as 
a proportion of those that were identified to possibly have trachoma. Individual screening coverage is the proportion 
of children in the target age group in a region that was actually screened. 
In 2012, population data for trachoma screening coverage were provided by each jurisdiction. For communities 
where population data were not provided, coverage estimates were based on the 2011 Australian census projected 
forward.15The population for communities in previous years was derived from projected data from the 2006 
Australian census using Australian Bureau of Statistics (ABS) standard estimates of population increase (1.6%, 1.8%, 
2.1% and 2.6% in the NT, WA, SA and Qld respectively). Population estimates for trichiasis screening coverage were 
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based on the projected 2011 Australian census data. Population estimates based on the 2011 census do not account 
for population movements within communities, regions and jurisdictions. Prevalence of active trachoma was 
calculated using the number of children screened as the denominator. 
Trachoma data were analysed in the age groups 1-4, 5-9 and 10-14 years. Comparisons over time were limited to the 
5-9-year age group, for which screening coverage has been consistently high. Data from 2006 were excluded from 
assessment of time trends as collection methods in this first year differed from those subsequently adopted. 
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National results 2012 
Figure 1.1 Trachoma prevalence in children aged 5-9 years, number of communities screened and number of 
at-risk communities in Australia, 2012 
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gure 1.2 Number of communities screened* by year and jurisdiction, Australia, 2007 - 2012 
 
*Including communities screened but not at risk 
Figure 1.3 Population screening coverage* of children aged 5-9 years by year and jurisdiction, Australia, 
2007-2012 
 
*Calculated as the number of children screened (in at-risk and not-at-risk communities) in region containing at least one at-risk community 
divided by the estimated region’s population 
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Figure 1.4 Proportion of screened children* aged 5-9 years who had a clean face by year and jurisdiction, 
Australia, 2007-2012 
 
*Including children in communities screened but not at risk 
Figure 1.5 Proportion of communities screened meeting clean face target* in children aged 5-9 years by year 
and jurisdiction, Australia, 2007-2012 
 
*  Clean face target is at least 80% of children within the community having a clean face at time of screening (Mariotti SP, Pruss A. The 
SAFE strategy. Preventing trachoma. A guide for environmental sanitation and improved hygiene. WHO/PBD/GET/00.7/Rev1. Geneva: World 
Health Organization; 2000)  
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Figure 1.6 Trachoma prevalence among screened* children aged 5-9 years by year and jurisdiction, Australia, 
2007-2012 
 
* Including children in communities screened but not at risk 
Figure 1.7 Proportion of screened* communities in which no trachoma was reported among children aged 5-
9 years by year and jurisdiction, Australia, 2007-2012 
 
*Including communities screened but not at risk 
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Figure 1.8 Proportion of screened communities* with endemic trachoma† among children aged 5-9 years by 
year and jurisdiction, Australia, 2007-2012 
 
*Including communities screened but not at risk 
†Prevalence greater than 5% 
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Figure 1.9 Proportion of screened at-risk communities* according to level of trachoma prevalence in 5-9-
year-old children in 2012, by jurisdiction, Australia 
 
*Two communities in Western Australia did not screen children in the 5-9 year age group. 
†Number of communities  
Figure 1.10  Trachoma prevalence among 5-9-year-old children in screened at-risk communities in 2012 by sex 
and jurisdiction, Australia 
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Table 1.1 Trachoma screening coverage, trachoma prevalence and clean face prevalence among at-risk Aboriginal communities in 2012 by jurisdiction, Australia  
  Northern Territory South Australia Western Australia Queensland Total 
Number of communities at 
risk 82 38 78 6 204 
Number of communities 
screened 76 36 77 6 195 
Age group (years) 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 
ABS estimated number of 
Aboriginal children at risk  3492 3981 3359 10832 942 961 855 2758 1965 2097 1896 5958 390 425 293 1108 6789 7464 6403 20656 
Jurisdiction Estimated number 
of Aboriginal children at risk  3091 3893 3733 10717   1176     524 2306 1387 4217 258 301 123 682 3873 7676 5243 15616 
Children examined for clean 
face 446 2640 1895 4981 14 930 323 1267 254 1709 811 2774 1 194 50 245 715 5473 3079 9267 
Children with clean face 293 1972 1719 3984 9 843 320 1172 179 1379 713 2271 1 136 50 187 482 4330 2802 7614 
Clean face prevalence 66% 75% 91% 80% 75% 90% 99% 93% 70% 81% 88% 82% 100% 70% 100% 76% 67% 79% 91% 82% 
Children examined for 
trachoma 362 2610 1908 4880 14 933 322 1269 244 1689 793 2726 1 194 52 247 621 5426 3075 9122 
Trachoma screening coverage  12% 67% 51% 46%   79%     47% 73% 57% 65% 0.4% 64% 42% 36% 16% 71% 59% 58% 
Children with active trachoma 24 117 35 176 0 13 1 14 6 71 34 111 0 0 0 0 30 201 70 301 
Active trachoma prevalence 7% 4% 2% 4% 0% 2% 0.3% 1% 2% 4% 4% 4% 0% 0% 0% 0% 5% 4% 2% 3% 
Trachoma prevalence 1-9 
years (weighted by 
population)* 
6% 1% 3% 0% 4% 
*Calculated as the proportion of children with active trachoma in age groups 1-4 and 5-9 years, weighted by the estimated population sizes of each age group. This calculation accounts for uneven coverage with 
respect to age groups
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Table 1.2 Trachoma treatment coverage among at-risk Aboriginal communities in 2012 by jurisdiction, Australia 
  Northern Territory South Australia Western Australia Queensland Total 
Number of 
communities at risk 82 38 78 6 204 
Number of 
communities 
screened 
76 36 77 6 195 
Number of 
communities 
requiring treatment 
43 9 35 0 87 
Number of 
communities treated 
according to CDNA 
guidelines* 
41 8 26   75 
Age group (years) 0-4 5-9 10-14 15+ All 0-4 5-9 10-14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 
Active cases 
requiring treatment 24 117 35   176 0 13 1   14 6 71 34   111           30 201 70   301 
Active cases who 
received treatment 23 114 33   170   13 1   14 6 68 29   103           29 195 63   287 
% Active cases 
received treatment 96% 97% 94%   97%   100% 100%   100% 100% 96% 85%   93%           97% 97% 90%   95% 
Estimated contacts 
requiring treatment  572 619 581 2532 4304 9 21 10 63 103 91 135 112 301 639           672 775 703 2896 5046 
Number of contacts 
who received 
treatment 
450 557 474 1911 3392 9 20 10 61 100 75 126 103 290 594           534 703 587 2262 4086 
% estimated 
contacts received 
treatment 
79% 90% 82% 75% 79% 100% 95% 100% 97% 97% 82% 93% 92% 96% 93%           79% 91% 83% 78% 81% 
Estimated overall 
treatment coverage 79% 91% 82% 75% 80% 100% 97% 100% 97% 97% 84% 94% 90% 96% 93%           80% 92% 84% 78% 82% 
 
* Communicable Diseases Network Australia. Guidelines for the public health management of trachoma in Australia. March 2006  
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Table 1.3 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults aged over 40 years in 2012, Australia 
  
Northern Territory South Australia Western Australia Total 
Number of communities at 
risk 82 38 78 198 
Number of communities 
screened for trichiasis 42(51%) * 14 (37%) 52 (69%) 108 (52%) 
Adult population of at-risk 
communities 7030 2246 4130 13406 
Adults examined (% of 
estimated population at 
risk) 
1278 (18%) 1061 (47%) 2129 (52%) 4468 (31%) 
With trichiasis (% of adults 
examined) 61 (5%) 11 (1%) 22 (1%) 94 (2%) 
Offered ophthalmic 
consultation 49 11 22 82 
Surgery in past 12 months 5 2 9 16 
* Twenty-eight further communities were screened in the NT, however findings were not made available to the NTSRU 
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Northern Territory results 2012 
Screening coverage 
• At-risk community coverage of trachoma screening over the five regions with endemic trachoma in the NT 
was 93%, with 76 out of 82 at-risk communities screened (Table 2.1).  
• Between 2011 and 2012 an increase in the number of communities screened is observed in the Katherine 
region and a slight decrease in the Barkly region. Screening coverage has plateaued in all other regions over the last 
3 years (Figure 2.2). 
• The proportion of children aged 5-9 years screened in the 76 at-risk communities was 67% with screening 
coverage ranging from 47% to 86% (Table 2.1, Figure 2.3). 
• The screening coverage of children aged 5-9 years in at-risk communities has increased in all regions of the 
NT since 2008 (Figure 2.3).  
• Screening was undertaken in the Town Camps of Alice Springs Urban region; however that data was not 
made available to the NTSRU 
Clean face prevalence 
• The overall prevalence of clean faces among 5-9-year-old children screened in the NT was 75%. The highest 
levels were found in the Darwin Rural region (Table 2.1, Figure 2.4). 
Trachoma prevalence 
• The prevalence of trachoma in children aged 5-9 years screened in the NT was 4%. Prevalence ranged from 
1% in East Arnhem and Darwin Rural regions to 9% in Alice Springs Remote region (Table 2.1, Figure 2.5). 
• No active trachoma was detected in 53% (40/76) of communities screened (Figure 2.6), an increase in the 
proportion of communities screened with no active trachoma from 34% in 2011. 
• A decreasing trend continues in the percentage of communities with endemic trachoma (prevalence greater 
than 5%), from 63% in 2010, to 46% in 2011 to 28% in 2012 (Figure 1.8).  
• A decreasing trend since 2008 in trachoma prevalence among 5-9-year old children is observed in all regions 
of the NT (Figure 2.5).  
• The greatest decrease in trachoma prevalence among 5-9-year children between 2011 and 2012 was 
observed in Alice Springs Remote region with a prevalence of 9% in 2012 compared with 14% in 2011 (Table 2.1, 
Figure 2.5). 
• The highest prevalence of trachoma among children aged 5-9 years was 37%, recorded within a community 
in the Alice Springs Remote region where more than 50 children aged 5-9 years were screened. 
• Verbal reports regarding Camps of Alice Springs Urban region were that trachoma prevalence was less than 
5% 
Treatment coverage 
• Treatment for trachoma was required for 43 of the 76 at-risk communities screened (Table 2.2). 
• Of the cases of active trachoma detected at screening, 97% received treatment (Table 2.2). 
• Azithromycin was used to treat 79% of the contact population (Table 2.2).  
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• Of the 43 communities requiring treatment, 41 communities were treated according to CDNA Guidelines. 
• Six communities received a second community-wide treatment of azithromycin, with overall treatment 
coverage of 70% in these six communities for the second treatment (Table 2.3). 
Trichiasis 
• Trichiasis screening data was provided for 51% (42/82) of at-risk communities, with 18% (1278/7030) of the 
at-risk population screened (Table 2.4). 
• It is understood that screening was undertaken in a further 28 communities, however data was not made 
available to the NTRSU 
• Trichiasis was detected in 5% of the adults screened (Table 2.4). 
• Five cases of trichiasis were reported to have received surgery (Table 2.4). 
Health promotion 
• Health promotion activities were reported in 23% (19/82) communities at risk, with an overall 45 health 
promotion initiatives reported (Table 2.5).   
• Of the health promotion initiatives reported, 38% (17/45) activities were directed at children; 36% (16/45) 
used a group presentation method and 40% (18/45) reported delivering activities 2-4 times throughout the year 
(Table 2.5).  
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Figure 2.1 Trachoma prevalence in children aged 5-9 years, number of communities screened and number of 
at-risk communities in the Northern Territory in 2012
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Figure 2.2 Number of communities screened* by year and region in the Northern Territory, 2007-2012 
 
*Including communities screened but not at risk 
Figure 2.3 Population screening coverage* of children aged 5-9 years in regions containing at least one at-risk 
community by year and region in the Northern Territory, 2007-2012 
 
*Including children in communities screened but not at risk 
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Figure 2.4 Proportion of screened* children aged 5-9 years who had a clean face by year and region in the 
Northern Territory, 2007-2012 
 
*Including children in communities screened but not at risk 
Figure 2.5 Trachoma prevalence among screened* children aged 5-9 years by year and region in the Northern 
Territory, 2007-2012 
 
*Including children in communities screened but not at risk 
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Figure 2.6  Trachoma prevalence among children 5-9 years in screened at-risk communities in 2012 by 
Northern Territory region  
 
*Number of communities 
Figure 2.7 Trachoma prevalence among 5-9-year-old children in screened at-risk communities in 2012 by sex 
and Northern Territory region 
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 Table 2.1 Trachoma screening coverage, trachoma prevalence and clean face prevalence in the Northern Territory in 2012 by region 
  
Alice Springs 
Remote Barkly Darwin Rural East Arnhem Katherine Total 
Number of 
communities at risk 30 7 16 10 19 82 
Number of 
communities screened 28 6 15 8 19 76 
Age group (years) 1-4 5-9 10-14 1-14 1-4 5-9 
10-
14 
1-
14 1-4 5-9 
10-
14 1-14 1-4 5-9 
10-
14 1-14 1-4 5-9 
10-
14 1-14 1-4 5-9 
10-
14 1-14 
ABS estimated 
number of Aboriginal 
children at risk  
823 843 728 2394 158 226 163 547 1049 1244 976 3269 776 980 859 2615 686 688 633 2007 3492 3981 3359 10832 
Jurisdiction Estimated 
number of Aboriginal 
children at risk  
573 879 735 2187 48 186 130 364 861 1143 1064 3068 903 939 1010 2852 706 746 794 2246 3091 3893 3733 10717 
Children examined for 
clean face 143 773 499 1415 27 152 117 296 131 711 555 1397 14 452 337 803 131 552 387 1070 446 2640 1895 4981 
Children with clean 
face 56 364 401 821 19 131 115 265 100 641 524 1265 9 359 311 679 109 477 368 954 293 1972 1719 3984 
Clean face prevalence 39% 47% 80% 58% 70% 86% 98% 90% 76% 90% 94% 91% 64% 79% 92% 85% 83% 86% 95% 89% 66% 75% 91% 80% 
Children examined for 
trachoma 81 757 499 1337 15 146 116 277 138 723 574 1435 9 445 335 789 119 539 384 1042 362 2610 1908 4880 
Trachoma screening 
coverage 14% 86% 68% 61% 31% 78% 89% 76% 16% 63% 54% 47% 1% 47% 33% 28% 17% 72% 48% 46% 12% 67% 51% 46% 
Children with active 
trachoma 7 69 18 94 2 8 5 15 5 7 3 15 0 6 1 7 10 27 8 45 24 117 35 176 
Active trachoma 
prevalence 9% 9% 4% 7% 13% 5% 4% 5% 4% 1% 1% 1% 0% 1% 0% 1% 8% 5% 2% 4% 7% 4% 2% 4% 
Trachoma prevalence 
1-9 years (weighted by 
population)* 
9% 9% 2% 1% 7% 6% 
* Calculated as the proportions of children with active trachoma in age groups 1-4 and 5-9 years, weighted by the estimated population sizes of each age group. This calculation accounts for uneven coverage with respect to age groups 
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Table 2.2 Trachoma treatment coverage in the Northern Territory in 2012 
 Alice Springs Remote Barkly  Darwin Remote East Arnhem Katherine Total 
Number of 
communitie
s at risk 
30 7 16 10 19 82 
Number of 
communitie
s screened 
28 6 15 8 19 76 
Number of 
communitie
s requiring 
treatment 
18 5 7 5 8 43 
Number of 
communitie
s treated 
according to 
CDNA 
guidelines* 
17 5 6 5 8 41 
Age group 
(years) 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 0-4 5-9 
10-
14 15+ All 
Active cases 
requiring 
treatment 
7 69 18   94 2 8 5   15 5 7 3   15 0 6 1   7 10 27 8   45 24 117 35   176 
Active cases 
received 
treatment  
7 67 17   91 2 8 5   15 4 6 2   12 0 6 1   7 10 27 8   45 23 114 33   170 
% Active 
cases 
received 
treatment  
100
% 
97
% 
94
%   97% 
100
% 
100
% 
100
%   
100
% 
80
% 
86
% 
67
%   
80
%   
100
% 
100
%   
100
% 
100
% 
100
% 
100
%   
100
% 
96
% 
97
% 
94
%   97% 
Estimated 
contacts 
requiring 
treatment  
378 432 390 1715 
291
5 19 29 13 69 130 25 19 14 66 124 18 15 22 92 147 132 124 142 590 988 572 619 581 
253
2 
430
4 
Total 
number of 
contacts 
who 
received 
treatment 
282 388 306 1149 
212
5 19 29 13 68 129 24 16 10 59 109 18 15 22 92 147 107 109 123 543 882 450 557 474 
191
1 
339
2 
% estimated 
contacts 
received 
treatment  
75% 90% 
78
% 67% 73% 
100
% 
100
% 
100
% 
99
% 99% 
96
% 
84
% 
71
% 
89
% 
88
% 
100
% 
100
% 
100
% 
100
% 
100
% 81% 88% 87% 
92
% 89% 
79
% 
90
% 
82
% 75% 79% 
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 Alice Springs Remote Barkly  Darwin Remote East Arnhem Katherine Total 
Estimated 
overall 
treatment 
coverage  
75% 91% 
79
% 67% 74% 
100
% 
100
% 
100
% 
99
% 99% 
93
% 
85
% 
71
% 
89
% 
87
% 
100
% 
100
% 
100
% 
100
% 
100
% 82% 90% 87% 
92
% 90% 
79
% 
91
% 
82
% 75% 80% 
*Communicable Diseases Network Australia. Guidelines for the public health management of trachoma in Australia. March 2006.
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Table 2.3 Treatment coverage for second treatment of trachoma in hyperendemic communities in the Northern Territory in 2012 
  Alice Springs Remote Darwin Remote Total 
Number of communities that 
received second treatment in a 
calendar year 
4 2 6 
Age group (years) 0-4 5-9 10-14 15+ All 0-4 5-9 10-14 15+ All 0-4 5-9 10-14 15+ All 
Estimated Number of contacts 
requiring treatment‡ 90 105 83 369 647 360 592 548 3353 4853 450 697 631 3722 5500 
Number of cases and contacts who 
received a second treatment 79 105 76 296 556 371 406 323 2181 3281 450 511 399 2477 3837 
Estimated overall second treatment 
coverage  88% 100% 92% 80% 86% 103% 69% 59% 65% 68% 100% 73% 63% 67% 70% 
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Table 2.4 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults aged over 40 years in 2012 in the Northern Territory 
  Alice Springs Remote Barkly Darwin Rural East Arnhem Katherine Total 
Number of communities at 
risk 30 7 16 10 19 82 
Number of communities 
screened for trichiasis 11 (37%) 0 (0%) 16 (100%) 7 (70%) 8 (42%) 42 (51%)* 
Adult population of at-risk 
communities 1773 274 2090 1810 1083 7030 
Adults examined (% of 
estimated population at risk) 175 (10%) 0 (0%) 879 (42%) 41 (2%) 183 (17%) 1278 (18%) 
With trichiasis (% of adults 
examined) 26 (15%)   32 (4%) 0 3 (2%) 61 (5%) 
Offered ophthalmic 
consultation 17 0 32 0 0 49 
Surgery in past 12 months 5 0 0 0 0 5 
* Twenty-eight further communities were screened across all regions, however findings were not made available to the NTSRU
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Table 2.5 Health promotion activities by region in the Northern Territory in 2012 
  Alice Springs Remote Barkly Darwin Rural East Arnhem Katherine Total 
Number of communities at-risk 30 7 16 10 19 82 
Number of communities who 
reported health promotion activities 6 1 3 0 9 19 
Methods of Health Promotion   
One-on-one discussion 2 12%     3 43%     5 29% 10 22% 
Presentationto group 5 29%     3 43%     8 47% 16 36% 
Interactive group session 5 29% 2 100% 1 14%     4 24% 12 27% 
Social Marketing 3 18%                 3 7% 
Print material 2 12%                 2 4% 
Mass Media 1 6%                 1 2% 
Sporting/community events 1 6%                 1 2% 
Other                     0 0% 
Total number of programs 19   2   7   0   17   45   
Target audience                         
Health professionals/staff 2 12%     1 14%     1 6% 4 9% 
Children 6 35% 1 50% 3 43%     7 41% 17 38% 
Youth 2 12%             3 18% 5 11% 
Teachers/childcare/preschool staff 3 18% 1 50% 1 14%     3 18% 8 18% 
Caregivers/parents 1 6%     1 14%     3 18% 5 11% 
Community members 4 24%     1 14%         5 11% 
Community educators/health 
promoters 1 6%     0 0%         1 2% 
Interagency members 0 0%     0 0%             
Frequency of health promotion 
activites                          
Once 3 18%                 3 7% 
Occasional * 9 53% 2 100% 7 100%         18 40% 
Regular† 4 24%                 4 9% 
Ongoing/routine 3 18%                 3 7% 
*2 -4 times per year 
†5-12 times per year 
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South Australia results 2012 
• The 2011 and 2012 regional data reported is different to that reported in previous years. Communities 
screened in previous years have been reclassified in this report for consistency with 2012 reporting. 
• Data collected to February 2013 in SA were included in this year’s report. 
• Some trend figures do not include data collected in 2010 due to differences in age ranges reported in 2010. 
Screening coverage 
• An increase in the number of at-risk communities screened was observed across all regions in SA in 2012 
(Figure 3.2). 
• At-risk community coverage of trachoma screening over the four at-risk regions was 95% with 36 out of 38 
at-risk communities screened (Table 3.1). 
• The proportion of children screened aged 5-9 years in at-risk regions was 79%with screening coverage 
ranging from 56% to 92% (Table 3.1, Figure 3.3). 
• Compared to 2011, the screening rates of children aged 5-9 years in at-risk communities decreased in the Far 
North region, and increased in all other regions in SA in 2012 (Figure 3.3). 
Clean face prevalence 
• The overall prevalence of clean faces among screened children aged 5-9 in SA was 90%, ranging from 77% to 
100% (Table 3.1, Figure 3.4). 
Trachoma prevalence 
• The overall prevalence of trachoma in children screened aged 5-9 years in SA was 2% (Table 3.1). 
• No active trachoma was detected in 81% (29/36) of at-risk communities screened in the 5-9 year age group 
(Figure 3.6). 
• A decreasing trend in the number of communities in SA with trachoma prevalence greater than 5% has been 
observed since 2008 (Figure 1.8). 
• No trachoma was detected in the Far North, and York and Mid North regions in the 5-9 year age group 
(Figure 3.6); however one case of trachoma was detected in the 10-14 year age group in the York and Mid North 
region (Table 3.1). 
• Comparing 2011 to 2012, lower trachoma prevalence among 5-9-year-old children is observed in both 
Anangu Pitjantjatjara Yankunytjatjara (APY) Lands, and Eyre and Western regions (Figure 3.5). 
• The highest prevalence of trachoma among children aged 5-9 years was 20% within a community in the APY 
Lands where less than 10 children were screened. 
Treatment coverage 
• Treatment was required for 9 of the 36 communities screened (Table 3.1, Table 3.2). 
• Of the active cases requiring treatment for trachoma, 100% received treatment (Table 3.2). 
• Azithromycin was used to treat the estimated 97% of the population requiring treatment (Table 3.2). 
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Trichiasis 
• Trichiasis screening was undertaken in all at-risk regions in SA in 2012, with 14 at-risk communities screened 
and 47% (1061/2246) of adults in these communities screened (Table 3.3).  
• Trichiasis was detected in 1% (11/1061) of adults screened (Table 3.3). 
Health promotion 
• Health promotion activities were reported in 92% (35/38) of at-risk communities, with an overall 112 health 
promotion initiatives reported. 
• Of the health promotion programs reported, 44% (49/112) of activities were directed at children and 44% 
(49/112) used a one-on-one discussion method. 
• Of the health promotion programs reported, 48% (54/112) of programs were delivered once only, 48% 
(54/112) of programs were delivered 2-4 times throughout the year, and 4% (4/112) reported that programs were 
delivered 5-12 times throughout 2012 (Table 3.4). 
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Figure 3.1 Trachoma prevalence in children aged 5-9 years, number of communities screened and number of 
communities at-risk in 2012 in South Australia. 
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Figure 3.2 Number of communities screened* by year and region in South Australia, 2007-2012 
 
* Including communities screened but not at risk 
Figure 3.3 Population screening coverage of children aged 5-9 years over all regions containing at least one 
at-risk community by year and region in South Australia, 2007-2012 
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Figure 3.4 Proportion of screened* children aged 5-9 years who had a clean face by year and region in South 
Australia, 2007-2012 
 
* Including children in communities screened but not at risk 
Figure 3.5 Trachoma prevalence among screened* children aged 5-9 years by year and region in South 
Australia, 2007-2012 
 
* Including children in communities screened but not at risk 
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Figure 3.6 Trachoma prevalence among children aged 5-9 years in screened at-risk communities in 2012 by 
region in South Australia 
 
* Number of communities 
Figure 3.7 Trachoma prevalence of 5-9-year-old children in screened at-risk communities in 2012 by sex and 
region in South Australia 
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Table 3.1 Trachoma screening coverage, trachoma prevalence and clean face prevalence in South Australia in 2012 by region 
  
APY Lands Eyre/Western Far North York and Mid North Total 
Number of communities at 
risk 9 6 8 15 38 
Number of communities 
screened 8 6 8 14 36 
Age group (years) 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 
ABS estimated number of 
Aboriginal children at risk  190 228 173 591 313 317 289 919 208 202 168 578 231 214 225 670 942 961 855 2758 
Jurisdiction Estimated 
number of Aboriginal 
children at risk  
  279       380       359       158       1176     
Children examined for 
clean face 0 242 0 242 6 344 67 417 8 199 161 368 0 145 95 240 14 930 323 1267 
Children with clean face   186   186 3 313 64 380 6 199 161 366 0 145 95 240 9 843 320 1172 
Clean face prevalence   77%   77% 50% 91% 96% 91% 75% 100% 100% 99%   100% 100% 100% 75% 90% 99% 93% 
Children examined for 
trachoma 0 242 0 242 6 344 67 417 8 202 161 371 0 145 94 239 14 933 322 1269 
Trachoma screening 
coverage   87%       91%       56%       92%       79%     
Children with active 
trachoma   10   10 0 3 0 3 0 0 0 0 0 0 1 1 0 13 1 14 
Active trachoma 
prevalence   4%   4% 0% 1% 0% 1% 0% 0% 0% 0%   0% 0% 0.2% 0% 2% 0.3% 1% 
Trachoma prevalence 1-9 
years (weighted by 
population)* 
1% 0% 0% 0% 1% 
* Calculated as the proportions of children with active trachoma in age groups 1-4 and 5-9 years, weighted by the estimated population sizes of each age group. This calculation accounts for uneven coverage 
with respect to age groups  
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Table 3.2 Treatment coverage in South Australia in 2012 by region 
  APY Lands Eyre/Western Far North York and Mid North Total 
Number of 
communities at risk 9 6 8 15 38 
Number of 
communities 
screened 
8 6 8 14 36 
Number of 
communities 
requiring treatment 
6 2 0 1 9 
Number of 
communities treated 
according to CDNA 
guidelines 
5 2 N/A 1 8 
Age group (years) 0-4 5-9 10-14 15+ All 0-4 5-9 10-14 15+ All 0-4 
5-
9 
10-
14 15+ All 
0-
4 
5-
9 10-14 15+ All 0-4 5-9 10-14 15+ All 
Active cases 
requiring treatment 0 10 0   10 0 3 0   3 0 0 0   0 0 0 1   1 0 13 1   14 
Active cases received 
treatment 0 10 0   10 0 3 0   3 0 0 0   0 0 0 1   1 0 13 1   14 
% Active cases 
received treatment   100%     100%   100%     100%               100%       100% 100%   100% 
Estimated contacts 
requiring treatment 
according to 
jurisdictional 
interpretation of the 
guidelines 
8 12 8 55 83 1 9 2 7 19 0 0 0   0 0 0 0 1 1 9 21 10 63 103 
Number of contacts 
who received 
treatment 
8 11 8 53 80 1 9 2 7 19 0 0 0   0 0 0 0 1 1 9 20 10 61 100 
% estimated contacts 
received treatment 100% 92% 100% 96% 96% 100% 100% 100% 100% 100%                 100% 100% 100% 95% 100% 97% 97% 
Estimated overall 
treatment coverage 100% 95% 100% 96% 97% 100% 100% 100% 100% 100%               100% 100% 100% 100% 97% 100% 97% 97% 
*Communicable Diseases Network Australia. Guidelines for the public health management of trachoma in Australia. March 2006 
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Table 3.3 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults aged over 40 years in 2012 in South Australia 
  APY Lands Eyre/Western Far North York and Mid North Total 
Number of communities at risk 9 6 8 15 38 
Number of communities screened for 
trichiasis 1 (11%) 4 (67%) 4 (50%) 5 (33%) 14 (37%) 
Adult population of at-risk communities 485 436 832 493 2246 
Adults examined (% of estimated 
population at risk) 287 (59%) 227 (52%) 350 (42%) 197 (40%) 1061 (47%) 
With trichiasis (% of adults examined) 10 (3%) 0 (0%) 1 (0.3%) 0 (0%) 11 (1%) 
Offered ophthalmic consultation 10 0 1 0 11 
Surgery in past 12 months 2 0 0 0 2 
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Table 3.4 Health promotion activities in South Australia in 2012 
  
APY Lands Eyre and Western Far North 
York and 
Midnorth Total 
Number of communities at-risk 9 6 8 15 38 
Number of communities who reported 
health promotion activities 8 5 8 14 35 
Methods of Health Promotion   
One-on-one discussion 8 50% 10 31% 12 43% 19 53% 49 44% 
Presentationto group 0 0% 7 22% 4 14% 0 0% 11 10% 
Interactive group session 0 0% 7 22% 1 4% 0 0% 8 7% 
Social Marketing 0 0% 5 16% 0 0% 0 0% 5 4% 
Print material 8 50% 2 6% 10 36% 17 47% 37 33% 
Mass Media 0 0% 0 0% 0 0% 0 0% 0 0% 
Sporting/community events 0 0% 1 3% 0 0% 0 0% 1 1% 
Other 0 0% 0 0% 1 4% 0 0% 1 1% 
Total number of programs 16   32   28   36   112   
Target audience   
Health professionals/staff 0 0% 6 19% 2 7% 33 92% 41 37% 
Children 16 100% 11 34% 22 79% 0 0% 49 44% 
Youth 0 0% 3 9% 2 7% 0 0% 5 4% 
Teachers/childcare/preschool staff 0 0% 6 19% 2 7% 2 6% 10 9% 
Caregivers/parents 0 0% 5 16% 0 0% 1 3% 6 5% 
Community members 0 0% 1 3% 0 0% 0 0% 1 1% 
Community educators/health promoters 0 0% 0 0% 0 0% 0 0% 0 0% 
Interagency members 0 0% 0 0% 0 0% 0 0% 0 0% 
Frequency of health promotion activites    
Once 16 100% 4 13% 20 71% 14 39% 54 48% 
Occasional * 0 0% 24 75% 8 29% 22 61% 54 48% 
Regular† 0 0% 4 13% 0 0% 0 0% 4 4% 
Ongoing/routine 0 0% 0 0% 0 0% 0 0% 0 0% 
* 2 -4 times per year 
†5-12 times per year 
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Western Australia results 2012 
Screening coverage 
• At-risk community coverage of trachoma screening in the four regions with endemic trachoma in WA was 
99%, with 77 out of 78 at-risk communities screened for trachoma (Table 4.1). 
• An increase of the number of communities screened was observed in the Goldfields region since 2011. 
However in 2011, 10 communities in this region were amalgamated into one distinct community for the purpose of 
presenting data in this report (Figure 4.2). 
• The number of communities screened across Kimberley and Midwest regions was constant between 2011 
and 2012 (Figure 4.2). 
• The proportion of children aged 5-9 years screened in at-risk regions was 73% (range 63 -  82%) (Table 4.1, 
Figure 4.3). 
• A substantial increase in trachoma screening among 5-9 year of children was observed in all regions since 
2011 and since screening data collection began in 2007 (Figure 4.3). 
Clean face prevalence 
• The overall prevalence of clean faces among 5-9-year-old children screened in WA was 81%. The highest rate 
was found in the Pilbara region (94%) (Table 4.1, Figure 4.4). 
Trachoma prevalence 
• The prevalence of trachoma among children aged 5-9 years who were screened in WA was 4%. Prevalence 
ranged from 2% to 10% (Table 4.1).  
• No active trachoma was detected in 61% (46/75) (Figure 4.6) of communities screened that screened 
children aged 5-9 years, an increase from 58% (40/69) in 2011.  
• A decreasing trend continues in the percentage of communities with trachoma prevalence greater than 5% 
(Figure 1.8), from 60% in 2009, to 50% in 2010, to 36% in 2011 and 29% in 2012. 
• Compared to 2011, trachoma prevalence in all regions in WA decreased in 2012 (Figure 4.5). 
• The highest prevalence of trachoma among children 5-9 years was 54% within a community in the Kimberley 
region where less than 20 children were screened.  
Treatment coverage 
• Treatment for trachoma was required for 35 of the 77 screened at-risk communities (Table 4.2). 
• Of the active cases of trachoma detected at screening, 93% were treated with azithromycin (Table 4.2). 
• Azithromycin was used to treat the estimated 93% of the population requiring treatment, however 
population data were not provided for six communities that treated active cases only (Table 4.2). 
• Of the 35 communities requiring treatment, 26 received treatment according to CDNA guidelines (Table 4.2). 
Trichiasis 
• Trichiasis screening was undertaken in all regions of WA, with 52% (2129/4130) of the estimated at-risk 
population screened (Table 4.3).  
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• Trichiasis was detected in 1% (22/2129) of adults screened (Table 4.3). 
• Nine cases of trichiasis were reported to have received surgery in the last 12 months (Table 4.3). 
Health promotion 
• Health promotion activities were reported in 93% (73/78) of at-risk communities, with an overall 263 health 
promotions initiaves reported (Table 4.4) 
• Of the initiatives reported, 42% (110/263) were directed toward children and 28% (74/263) used an 
interactive group session method. 
• Of the initiatives reported, 70% (183/263) reported delivering these programs 2-4 times in the year, and 10% 
(26/263) reported these programs were a routine and ongoing initiative within at-risk communities.  
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Figure 4.1 Trachoma prevalence in children aged 5-9 years, number of communities screened and number of 
communities at-risk in 2012 in Western Australia 
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Figure 4.2 Number of communities screened* by year and region in Western Australia, 2007-2012 
 
* Including communities screened but not at risk 
Figure 4.3 Population screening coverage* of children aged 5-9 years over all regions containing at least one 
at-risk community by year and region in Western Australia, 2007-2012 
 
* Including children in communities screened but not at risk 
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Figure 4.4 Proportion of screened children* aged 5-9 years who had a clean face by year and region in 
Western Australia, 2007-2012 
 
* Including children in communities screened but not at risk 
Figure 4.5 Trachoma prevalence among screened* children aged 5-9 years by year and region in Western 
Australia, 2007-2012 
 
* Including children in communities screened but not at risk 
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Figure 4.6 Trachoma prevalence among children aged 5-9 years in screened at-risk communities in 2012 by 
region in Western Australia  
 
* One community in both Goldfields and Pilbara did not screen children in the 5-9 year age group 
† Number of communities 
Figure 4.7 Trachoma prevalence of 5-9-year-old children in screened at-risk communities in 2012 by sex and 
region in Western Australia 
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Table 4.1 Trachoma screening coverage, trachoma prevalence, and clean face prevalence in Western Australia in 2012 by region 
  Goldfields Kimberley Midwest Pilbara Total 
Number of communities 
at risk 24 31 8 15 78 
Number of communities 
screened 23 31 8 15 77 
Age group (years) 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 1-4 5-9 10-14 1-14 
ABS estimated number 
of Aboriginal children at 
risk  
586 567 540 1693 898 1027 896 2821 115 128 140 383 366 375 320 1061 1965 2097 1896 5958 
Jurisdiction Estimated 
number of Aboriginal 
children at risk  
151 448 361 960 204 1379 622 2205 53 210 183 446 116 269 221 606 524 2306 1387 4217 
Children examined for 
clean face 60 365 221 646 96 992 260 1348 20 132 131 283 78 220 199 497 254 1709 811 2774 
Children with clean face 35 281 197 513 67 804 237 1108 14 88 87 189 63 206 192 461 179 1379 713 2271 
Clean face prevalence 58% 77% 89% 79% 70% 81% 91% 82% 70% 67% 66% 67% 81% 94% 96% 93% 70% 81% 88% 82% 
Children examined for 
trachoma 60 365 221 646 86 972 242 1300 20 132 131 283 78 220 199 497 244 1689 793 2726 
Trachoma screening 
coverage 40% 81% 61% 67% 42% 70% 39% 59% 38% 63% 72% 63% 67% 82% 90% 82% 47% 73% 57% 65% 
Children with active 
trachoma 3 37 22 62 1 23 5 29 1 5 4 10 1 6 3 10 6 71 34 111 
Active trachoma 
prevalence 5% 10% 10% 10% 1% 2% 2% 2% 5% 4% 3% 4% 1% 3% 2% 2% 2% 4% 4% 4% 
Trachoma prevalence 1-
9 years (weighted by 
population)  
8% 2% 4% 2% 3% 
*Calculated as the proportions of children with active trachoma in age groups 1-4 and 5-9 years, weighted by the estimated population sizes of each age group. This calculation accounts for uneven coverage with respect to age groups  
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Table 4.2 Treatment coverage in Western Australia in 2012 by region 
  
Goldfields Kimberley Midwest Pilbara Total 
Number of 
communities at risk 24 31 8 15 78 
Number of 
communities screened 23 31 8 15 77 
Number of 
communities requiring 
treatment 
15 11 4 5 35 
Number of 
communities treated 
according to CDNA 
guidelines* 
10 11 0 5 26 
Age group (years) 0-4 5-9 10-14 15+ All 0-4 5-10 10-15 15+ All 0-4 5-9 10-14 15+ All 0-4 5-9 10-14 15+ All 0-4 5-9 
10-
14 15+ All 
Active cases requiring 
treatment 3 37 22   62 1 23 5   29 1 5 4   10 1 6 3   10 6 71 34   111 
Active cases received 
treatment 3 36 19   58 1 22 3   26 1 4 4   9 1 6 3   10 6 68 29   103 
% Active cases 
received treatment 100% 97% 86%   94% 100% 96% 60%   90% 100% 80% 100%   90% 100% 100% 100%   100% 100% 96% 85%   93% 
Estimated contacts 
requiring treatment 
(according to 
jurisdictional 
interpretation of the 
guidelines) 
22 28 14 103 167 62 93 75 172 393 0 3 4 0 7 7 11 19 26 63 91 135 112 301 639 
Number of contacts 
who received 
treatment †  
21 28 14 98 161 58 87 69 166 372 0 0 1 0 1 7 11 19 26 63 75 126 103 290 594 
% Estimated contacts 
received treatment  †  
95% 100% 100% 95% 96% 94% 94% 92% 97% 95%   0% 25%   14% 100% 100% 100% 100% 100% 82% 93% 92% 96% 93% 
Estimated overall 
treatment coverage 
(total) †  
96% 98% 92% 95% 96% 94% 94% 90% 97% 94% 100% 50% 63%   59% 100% 100% 100% 100% 100% 84% 94% 90% 96% 93% 
*Communicable Diseases Network Australia. Guidelines for the public health management of trachoma in Australia. March 2006 
†Three communities in both Goldfield and Midwest regions did not provide estimates for contacts requiring treatment, and active cases only were treated  
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Table 4.3 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults aged over 40 years in 2012 in Western Australia 
  Goldfields Kimberley Midwest Pilbara  Total  
Number of communities at risk 24 31 8 15 78 
Number of communities 
screened for trichiasis 5 (21%) 25 (81%) 8 (100%) 14 (93%) 54  (69%) 
Estimated adult population of at 
risk communities (ABS) 1280 1860 269 721 4130 
Adults examined (% of 
estimated population at risk) 64 (5%) 1383 (74%) 377 (140%) 305 (42%) 2129 (52%) 
With trichiasis (% of adults 
examined) 0 (0%) 12 (1%) 0 (0%) 10 (3%) 22 (1%) 
Offered ophthalmic consultation 0 12 0 10 22 
Surgery in past 12 months 0 6 0 3 9 
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Table 4.4 Health promotion activities in Western Australia in 2012 
  
Goldfields Kimberley Midwest Pilbara  Total  
Number of communities at-risk 
24 31 8 15 78 
Number of communities who 
reported health promotion 
activities 
20 31 8 14 73 
Methods of Health Promotion   
One-on-one discussion 0 0% 5 6% 0 0% 33 47% 38 14% 
Presentationto group 0 0% 44 49% 0 0% 6 9% 50 19% 
Interactive group session 37 40% 13 15% 12 100% 12 17% 74 28% 
Social Marketing 11 12% 1 1% 0 0%   0% 12 5% 
Print material 36 39% 21 24% 0 0% 6 9% 63 24% 
Mass Media 0 0% 4 4% 0 0% 6 9% 10 4% 
Sporting/community events 0 0% 0 0% 0 0% 7 10% 7 3% 
Other 8 9% 1 1% 0 0% 0 0% 9 3% 
Total number of programs 92   89   12   70   263   
Target audience                     
Health professionals/staff 0 0% 2 2% 0 0% 5 7% 7 3% 
Children 47 51% 43 48% 6 50% 14 20% 110 42% 
Youth 0 0% 0 0% 0 0% 0 0% 0 0% 
Teachers/childcare/preschool 
staff 27 29% 18 20% 6 50% 8 11% 59 22% 
Caregivers/parents 0 0% 0 0% 0 0% 9 13% 9 3% 
Community members 10 11% 10 11% 0 0% 20 29% 40 15% 
Community educators/health 
promoters 8 9% 16 18% 0 0% 8 11% 32 12% 
Interagency members 0 0% 0 0% 0 0% 6 9% 6 2% 
Frequency of health 
promotion activites                      
Once 8 9% 12 13% 0 0% 0 0% 20 8% 
Occasional * 57 62% 74 83% 12 100% 40 57% 183 70% 
Regular† 10 11% 2 2% 0 0% 22 31% 34 13% 
Ongoing/routine 17 18% 1 1% 0 0% 8 11% 26 10% 
*2 -4 times per year 
†5-12 times per year 
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Queensland results 2012 
Screening coverage 
• Six potentially at-risk communities were selected and screened as a mapping exercise in Qld in 2012. 
• Community screening coverage for trachoma in children aged 5-9 years in these six communities was 64% 
(194/301) (Table 5.1). 
Clean face prevalence 
• The overall prevalence of clean faces among 5-9-year-old children screened in Qld was 70% (136/194) (Table 
5.1). 
Trachoma prevalence 
• No trachoma was reported in any of the six communities screened (Table 5.1).  
• In one community in the Torres Strait, follicles were observed in eight children. PCR swabs were taken from 
the eight children and household contacts.  Results from the PCR test were all negative for Chlamydia trachomatis. 
Treatment coverage 
• Treatment for trachoma was not required for any of the six communities screened (Table 5.1); however 
azithromycin was administered to the eight children and household contacts prior to the results of the PCR test 
being available. 
Health promotion 
• Health promotion activities were reported in all six communities deemed potentially at-risk (Table 5.2)  
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Figure 5.1 Trachoma prevalence of 5-9-year-old children, number of communities screened and number of 
at-risk communities in Queensland in 2012 
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Table 5.1 Trachoma screening coverage, trachoma prevalence, and clean face prevalence in Queensland in 
2012. 
Number of communities at risk 6 
Number of communities 
screened 6 
Age group (years) 1-4 5-9 10-14 1-14 
ABS estimated number of 
Aboriginal children at risk  390 425 293 1108 
Jurisdiction Estimated number 
of Aboriginal children at risk  258 301 123 682 
Children examined for clean 
face 1 194 50 245 
Children with clean face 1 136 50 187 
Clean face prevalence 100% 70% 100% 76% 
Children examined for 
trachoma 1 194 52 247 
Trachoma screening coverage * 0.4% 64% 42% 36% 
Children with active trachoma 0 0 0 0 
Active trachoma prevalence 0% 0% 0% 0% 
Trachoma prevalence 1-9 years 
(weighted by population)* 0% 
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Table 5.2 Health promotion activities in Queensland in 2012 
  
  
Number of communities at-risk 6 
Number of communities who reported 
health promotion activities 6 
Methods of Health Promotion   
One-on-one discussion  
Presentation to group   
Interactive group session  
Social Marketing  
Print material  
Mass Media  
Sporting/community events   
Other   
Target audience   
Health professionals/staff  
Children  
Youth   
Teachers/childcare/preschool staff  
Caregivers/parents  
Community members   
Community educators/health promoters   
Interagency members   
Frequency of health promotion 
activites    
Once   
Occasional *  
Regular†   
Ongoing/routine   
*2 -4 times per year 
†5-12 times per year 
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Discussion 
Screening coverage 
Screening coverage was measured as both the proportion of at-risk communities screened and the proportion of 5-
9-year-old children screened in at-risk communities, predominantly through primary school-based initiatives. 
Screening of older (10-14-year-old) and younger (1-4-year-old) children also takes place, but less consistently, and in 
2012 many regions chose to focus screening exercises solely on the 5-9-year age group. In 2012 population estimates 
provided by jurisdictions were used to calculate proportions. The manner in which the populations were calculated 
differed among jurisdictions, with some jurisdictions using school enrolment lists, Health Information populations 
lists, or a combination of both and local knowledge. The 2011 Australian Bureau of Statistics (ABS) census projected 
population estimates were included in the tables to provide a comparison. Population estimates were generally 
similar for the 5-9-year age group except in Qld. In 2012 all regions, increased trachoma screening coverage of 5-9-
year-old children except Darwin Rural region in the NT and Far North region in SA, compared to 2011 data. A higher 
screening coverage provides confidence that those screened are representative of the community at risk, and results 
are therefore an accurate reflection of the prevalence of disease within the community.   
The number of at-risk communities screened has increased in the NT, SA and WA. It is expected, however, that this 
will plateau and in some regions decrease in future years. A number of communities screened for the first time in 
2012 did not have trachoma, and therefore do not qualify as being at-risk for future years.   
The Guidelines for the public health management of trachoma in Australia is currently undergoing review. The new 
guidelines will allow hyperendemic communities to focus resources on treatment without the need for repeat 
screening for up to 3 years. If endorsed, this strategy will affect the number of communities screened and the 
regional screening coverage of children. The impact of this strategy may not be apparent for several years.   
Trachoma prevalence 
Endemic trachoma is defined by WHO as a prevalence of active trachoma of 5% or more in children aged 1-9 years. 
In past years the National Trachoma Surveillance and Reporting Unit (NTSRU) has been able to estimate the 
prevalence using population weights. Due to the poor screening coverage of the 1-4-year age group, it was 
considered that the results reported were not representative of that age group. In Australia, the prevalence in the 5-
9-year age group is accepted as a sufficient measure of the prevalence of trachoma within at-risk communities.   
Across all four jurisdictions in 2012, the prevalence of trachoma in 5-9-year-old children was 4%. This is a decrease 
from the 2011 national prevalence of trachoma in 5-9-yearold children of 7%.9 At a regional level in 2012, the 
prevalence of trachoma in children aged 5-9 years ranged from 0% to 4%. 
Queensland detected no trachoma in any of the six communities screened.  Follicles consistent with Trachomatous 
inflammation – follicular were observed in one community, however PCR tests results taken from children with 
follicles and their household contacts were negative for Chlamydia trachomatis.  Subsequently, Queensland has 
concluded that trachoma is not a public health concern for Queensland.  
In all other jurisdictions screened, a decreasing trend in trachoma prevalence is observed since 2009.  Decreasing 
trends in the NT, SA and WA were also observed in the number of communities found to have a prevalence greater 
than 5% (endemic trachoma) in screened children aged 5-9 years, and there was an increasing trend in the number 
of communities that reported no trachoma in screened children aged 5-9 years It may be timely to review the risk 
classifications of communities that reported no evidence of trachoma, presently or historically, such as three in the 
Darwin Rural region, four in the Katherine region (NT); one in Eyre and Western region, seven in the Far North 
region, all of the York and Mid North region (SA); two in the Goldfields region, two in the Midwest region and three 
in the Kimberley region (WA). 
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 The target set by both WHO and CDNA for elimination of blinding trachoma is community prevalence in children 
aged 1-9 years of less than 5% over a period of 5 years. Several communities designated as at-risk have reported a 
prevalence of less than 5% over the past 4 years, and are therefore on track to be designated not at-risk if this status 
is maintained for one more year. 
As these communities are reclassified as being not at-risk, future prevalence trends may increase for a period of time 
as the at-risk population becomes more concentrated.  
In 2012 the NTSRU collected prevalence data by sex. These data had not been collected in previous years. There is 
evidence in many trachoma endemic countries that women are disproportionately more likely to be at risk of 
trachoma, and become blind due to trichiasis.16 However, the national results from 2012 illustrate that males in all 
endemic Australian jurisdictions had a higher prevalence of trachoma compared to females. 
Trachoma treatment 
CDNA guidelines recommend the treatment of active cases and their household contacts. When prevalence is 
greater than 10% and cases are not clustered within a few households, community-wide treatment is suggested. The 
approach to community-wide treatment differs across jurisdictions. In the NT, the recommendation is taken to mean 
the entire community, whereas SA and WA choose to treat all children aged between 6 months and 14 years. The 
differences in approach are a response to the average number of contacts per active case in each jurisdiction: in the 
NT 1:24, 1:7 in SA and 1:6 in WA. 
Ninety-five percent of active cases received treatment.  
In 2012 jurisdictions supplied estimates of the populations requiring treatment. These estimates were influenced by 
the interpretation of the current treatment guidelines. For six communities in WA in which only active cases were 
treated, estimates of the number of household contacts or community members requiring treatment were not 
obtained; therefore treatment coverage was underestimated for WA. Nationwide, 75 of the 87 communities that 
required treatment were treated according to their jurisdictional interpretation of the current CDNA treatment 
guidelines.  
The NT also undertook 6-monthly treatment of all members of the community in six communities that detected 
hyperendemic levels of trachoma and achieved an overall coverage level of 70% for the second treatment. 
Trichiasis 
Coverage of screening for trichiasis among Aboriginal adults aged over 40 years in the NT, SA and WA increased in 
2012; however coverage remained low, with screening rates of 18% in the NT, 47% in SA and 52% in WA. Of the 
adults screened in communities designated as at risk for trachoma, 2% (94/4468) prevalence levels include only data 
collected in communities currently designated “at-risk”, and do not take into account the possibility that endemic 
areas may have changed over time.  
In 2012, sixteen cases of trichiasis surgery were reported in NT (5), SA (2) and WA (9).  
Facial cleanliness 
Facial cleanliness is a major component of the SAFE strategy, recognising that the presence of nasal and ocular 
discharge significantly correlates to the risk for both acquiring and transmitting trachoma. The proportion of 5-9-
year-old children screened who had clean faces increased slightly in all jurisdictions compared to 2011. WHO has set 
targets for communities to reach a rate of 80% facial cleanliness.17  This target was achieved by 58% of all screened 
communities nationally. 
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Program delivery and monitoring 
Significant improvements in program delivery have been reported in 2012 with increased coverage of screening and 
treatment delivery and health promotion activities. Data quality also improved in all jurisdictions; however, as many 
regions chose to focus on the 5-9-year age group, data regarding the 1-4-year age group were not comprehensive. 
The NTSRU in 2011 developed a web-based data entry system that minimised duplicates and inconsistent entry. This 
database is being enhanced to allow improved accessibility in the field and report generation for jurisdictions. 
In 2011, CDNA initiated a review of the 2006 CDNA Guidelines for the public health management of trachoma in 
Australia. The revised guidelines are expected to be endorsed by CDNA in 2013. This revised document aims to 
reduce the ambiguity and provide clear guidance on screening and treatment methods.  
Progress towards Australia’s elimination target 
As a signatory to the WHO Alliance of the Global Elimination of Blinding Trachoma by the year 2020 (GET 2020), 
Australia is committed to ensuring that trachoma levels continue to decrease to below endemic levels in at-risk 
communities. This report has shown significant decreases in trachoma prevalence in NT, SA and WA. With the 
implementation of new guidelines in 2013 and sustained efforts, as reported in 2012, Australia remains on course to 
eliminate trachoma by 2020.   
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Appendix 
Appendix 1. WHO grading card. 
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Appendix 2. Trachoma screening forms 
Summary form 1: Active cases of trachoma  
  
State/Territory       
Region:       
Community:       
School:       
Date/s of screening:       
 
Male children screened for trachoma 
 Age (in years) 
1-4 5-9 10-14 
M1. Estimated number of Aboriginal children in the community/school                   
M2. Number of children examined for trachoma                   
M3. Number of children with TI                   
M4. Number of children with TF                   
M5. Number of children with active trachoma (TF and/or TI)                   
M6.Number of children with TS                   
M7. Number of children examined for clean face                   
M8. Number of children with clean face                   
M9. Number of children with absence of clean face and active trachoma                   
M10. Number of children requiring treatment with azithromycin                   
M11. Number of active cases who received treatment with azithromycin in 
total 
                  
M12. Number of active cases who received treatment with azithromycin 
within two weeks of screening 
                  
 
Female children screened for trachoma 
 Age (in years) 
1-4 5-9 10-14 
F1. Estimated number of Aboriginal children in the community/school                   
F2. Number of children examined for trachoma                   
F3. Number of children with TI                   
F4. Number of children with TF                   
F5. Number of children with active trachoma (TF and/or TI)                   
F6. Number of children with TS                   
F7. Number of children examined for clean face                   
F8. Number of children with clean face                   
F9. Number of children with absence of clean face and active trachoma                   
F10. Number of children requiring treatment with azithromycin                   
F11. Number of active cases who received treatment with azithromycin in 
total 
                  
F12. Number of active cases who received treatment with azithromycin 
within two weeks of screening 
                  
  
72 
 
Summary form 2: Household and community treatment 
  
State/Territory       
Region:       
Community:       
School:       
Date/s of screening:       
 
All Children Screened for trachoma 
 Age (in years) 
 
0 -  4 5 – 9 10 - 14 
1.  Number of ALL children examined for trachoma                   
2.  Number of ALL children with active trachoma (TF and/or TI)                   
3.  Active trachoma prevalence in children                    
4. Were cases obviously clustered in several households in the 
community (please tick)?  Yes  No 
5. Treatment Strategy (please tick one only):   Household  
 Community 
 Active Cases only 
 No treatment given 
 No treatment required( 
prevalence=0) 
 
CDNA guidelines recommendation for treatment: 
• If prevalence >10% in children & no clustering: Community treatment required: 
Treat Aboriginal children 6 months to 14 years in community and all household contacts aged 6 
months and over all  
• All other situations: Household treatment required 
Treat all household contacts aged 6 months and over 
 
Treatment of Household contacts and community members (not including active cases) 
6. Number of households requiring treatment       
7. Number of households treated       
8. Date of first treatment       
9. Date of last treatment       
 Age (in years) 
0 1-4 5-9 10-14 15 + 
M F M F M F M F M F 
10. Number of household and community 
contacts requiring treatment with 
azithromycin 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
11. Number of household and community 
contacts who received treatment with 
azithromycin 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
12. Number of household and community 
contacts who received treatment with 
azithromycin within two weeks of screening 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
13. Number of household and community 
contacts who received treatment with 
azithromycin within two weeks of 
commencement of treatment. 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
14. Treatment delayed due to (Please tick):   Sorry business  Weather  Other 
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Summary Form 3: Trichiasis 
 
State/Territory       
Region:       
Community:       
Date/Year of screening       
 
 Sex/Age (in years) 
Male Female 
15-39 40-49 50+ 15-39 40-49 50+ 
Number of Aboriginal adults in age group                                     
Number of Aboriginal adults examined for trichiasis                                     
Number of Aboriginal adults with trichiasis                                     
Number of Aboriginal adults with trichiasis who 
were offered ophthalmological consultation within 6 
months of the previous screening 
                                    
Number of Aboriginal adults with trichiasis who 
declined  ophthalmological consultation within 6 
months of the previous screening 
      
Number of Aboriginal adults who underwent 
trichiasis surgery in the last year 
                                    
 
  
  
Summary form 4: Health Promotion 
 
State/Territory       
Region:       
Community:       
School:       Program Name  
 
     
Method 
 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
 One –on-one  
 Presentation to group 
 Interactive group 
session 
 Social 
marketing/internet 
 Print Material 
 Mass media  
 Sporting/community 
events 
 Other 
Target Audience 
 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
 Health professional staff 
 Children/school 
students 
 Youth 
 Teachers/childcare or 
preschool staff 
 Care givers - e.g. 
Mothers 
 Community members 
 Community educators or 
health promoters 
 Interagency members 
Estimated Coverage 
% 
 
      
Frequency 
 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
 Occasional 
 (2-4 times/year) 
Regular 
 (5-12 times/year) 
Ongoing/routine 
(daily/weekly) 
 please specify duration 
Comments 
 
 
      
 Appendix 3.  De-identified community trachoma prevalence trends by regions 
Figure A.1  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community * 
in North Alice Springs Remote region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
Figure A.2  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community * 
in South Alice Springs Remote region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
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 Figure A.3  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in Barkly region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
Figure A.4  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in Darwin Rural region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
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 Figure A.5  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in East Arnhem region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
Figure A.6  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in Katherine region, Northern Territory, 2007-2012 
 
* Where more than 10 children were screened 
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 Figure A.7 Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* in 
Anangu Pitjantjatjara Yankunytjatjara (APY) Lands region, South Australia, 2007-2012 
 
* Where more than 10 children were screened 
Figure A.8 Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* in 
Eyre and Western region, South Australia, 2007-2012 
 
* Where more than 10 children were screen  
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 Figure A.9  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in Goldfields region, Western Australia, 2012  
  
* Where more than 10 children were screened 
Figure A.10 Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* in 
West Kimberly region, Western Australia, 2012  
 
* Where more than 10 children were screened 
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 Figure A.11  Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* 
in East Kimberly region, Western Australia, 2012  
 
* Where more than 10 children were screened 
Figure A.12 Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* in 
Midwest region, Western Australia, 2012  
 
* Where more than 10 children were screened 
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 Figure A.13 Trachoma prevalence of screened children aged 5-9 years by year and de-identified community* in 
Pilbara region, Western Australia, 2007-2012  
 
* Where more than 10 children were screened 
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